Molecular diagnostics makes it possible to determine Immunoglobulin E (IgE) not only in molecules of individual (major) allergens, but also to panallergens of molecules of cross-reacting (minor) allergens, which greatly increases the accuracy of allergological diagnostics.
The ImmunoCAP® ISAC molecular diagnostic method has a number of characteristics and advantages:
- It allows you to determine the true allergy or reactions due to cross-reactivity.
- The ability to determine and predict the severity of allergic reactions.
- It helps to assess the risk of systemic allergic reactions, without conducting provocative tests.
- Monitoring and forecasting the effectiveness of ASIT (allergen-specific immunotherapy).
- It allows you to identify allergies even when other diagnostic methods are not informative enough.
- The possibility of early diagnosis of allergies, and, consequently, its prevention.
- The possibility of using capillary blood, which allows the technology to be used for the youngest patients.
Indications for ImmunoCAP® ISAC molecular diagnostics:
- Difficult-to-diagnose cases.
- The lack of information about other methods of allergological examination.
- Patients with polyvalent sensitization.
- Assessment of the expediency and effectiveness of ASIT.
- Patients with idiopathic anaphylaxis.
Patients who do not have a positive reaction to the antiallergic treatment.
